| Victoria Marie Schleicher, BA | |
|
5707 N 22nd St, Tampa, FL 33610-4350 | |
| (813) 272-2878 | |
| (813) 272-3766 |
| Full Name | Victoria Marie Schleicher |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 5707 N 22nd St, Tampa, Florida |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013124361 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Victoria Marie Schleicher, BA 5707 N 22nd St, Tampa, FL 33610-4350 Ph: (813) 272-2878 | Victoria Marie Schleicher, BA 5707 N 22nd St, Tampa, FL 33610-4350 Ph: (813) 272-2878 |
News Archive
Bedfont, based in the UK, specialists in the design and manufacture of breath analysis medical products, has made an FDA 510(k) submission for clearance to sell one of its breath analyzers, the ToxCO.
A pair of biomarkers of brain function - one that represents "listening effort," and another that measures ability to process rapid changes in frequencies - may help to explain why a person with normal hearing may struggle to follow conversations in noisy environments, according to a new study led by Massachusetts Eye and Ear researchers.
It's a disease that sneaks up on you. Fingers and toes slowly but surely become stiff and painful. A nice morning stretch is no longer all it takes to get your body moving. Arthritis is a chronic illness that sinks its claws into your body, and causes inflammation in your joints.
Aegerion Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the development and commercialisation of novel, life-altering therapies for patients with debilitating, often fatal, rare diseases, announced today that the European Commission has authorised Lojuxta (lomitapide) hard capsules as an adjunct to a low-fat diet and other lipid-lowering medicinal products with or without low density lipoprotein apheresis in adult patients with homozygous familial hypercholesterolaemia.
Ascendis Pharma A/S, a clinical stage biotechnology company that applies its innovative TransCon technology to address significant unmet medical needs, today announced that it has initiated a Phase 1 single ascending dose study of TransCon Treprostinil in healthy volunteers.
› Verified 5 days ago
Darlene H Allen, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 5707 N 22nd St, Tampa, FL 33610 Phone: 813-239-8000 Fax: 813-272-3766 | |
Bryant C Barbour, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 4422 E Columbus Dr., Tampa, FL 33605 Phone: 813-384-4079 | |
Ms. Clarissia Brown, MSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2021 Busch Blvd, Tampa, FL 33612 Phone: 813-631-4370 Fax: 813-631-4399 | |
Sasha J Thompson, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 612 N Gomez Ave, Tampa, FL 33609 Phone: 813-787-1623 | |
Jennifer Faith Gobeli, Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 8905 Regents Park Dr Ste 230, Tampa, FL 33647 Phone: 727-314-5468 | |
Ms. Linda L Mann, LCSW, CAP Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 4422 E Columbus Dr, Tampa, FL 33605 Phone: 813-980-3866 Fax: 813-984-8374 | |
Amy Lynn Abdnour, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 200 S Hoover Blvd Ste 185, Tampa, FL 33609 Phone: 813-679-3845 |